Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: Short‐term and long‐term outcomes

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Hepatology

• Publication date

  2011-09-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/hep.24434PMID 21608000
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 50 Years down the line

  2013cited by this paper
• Mesenchymal stem cells differentiate into hepatocyte-like cells under different induction systems in hepatitis B patients with liver failure

  2011cited by this paper
• Bone marrow stem cells and liver regeneration.

  2010cited by this paper
• Stem Cell Therapy Improves the Outcome of Liver Resection in Cirrhotics

  2010cited by this paper
• Bone marrow‐derived stem cells in liver repair: 10 years down the line

  2010cited by this paper
• Chronic hepatitis B: Update 2009

  2009cited by this paper
• Human bone marrow mesenchymal stem cells are resistant to HBV infection during differentiation into hepatocytes in vivo and in vitro

  2009cited by this paper
• HEPATOLOGY: A home for hepatocellular cancer publications

  2009cited by this paper
• Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)

  2009cited by this paper
• Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I–II clinical trial

  2009cited by this paper
• Safety and efficacy of autologous bone marrow stem cell transplantation through hepatic artery for the treatment of chronic liver failure: a preliminary study.

  2008cited by this paper
• Autologous Infusion of Expanded Mobilized Adult Bone Marrow-Derived CD34+ Cells Into Patients With Alcoholic Liver Cirrhosis

  2008cited by this paper
• Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level

  2007cited by this paper
• Long‐term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver disease

  2007cited by this paper
• Comparison of biological characteristics of marrow mesenchymal stem cells in hepatitis B patients and normal adults.

  2007cited by this paper
• Pluripotency of mesenchymal stem cells derived from adult marrow

  2007cited by this paper
• Dose-Dependent Relationship of Bone Marrow Mesenchymal Stem Cells Transplantation to Cardiomyogenesis for Functional Regenerative Recovery after Myocardial Infarction

  2007cited by this paper
• A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction.

  2007cited by this paper
• Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells.

  2007cited by this paper
• Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.

  2006cited by this paper
• Improved Liver Function in Patients with Liver Cirrhosis After Autologous Bone Marrow Cell Infusion Therapy

  2006cited by this paper
• [A preliminary study of the homing capacity of allograft mesenchymal stem cells to rat liver].

  2005cited by this paper
• [A study on the sero-epidemiology of hepatitis B in Chinese population aged over 3-years old].

  2005cited by this paper
• Mesenchymal stem cells: progress toward promise.

  2005cited by this paper
• Natural History and Clinical Consequences of Hepatitis B Virus Infection

  2005cited by this paper
• [Treatment of severe liver damage with autologous bone marrow stem cell transplantation in human patients].

  2005cited by this paper
• [AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines].

  2004cited by this paper
• Host cell-derived cardiomyocytes in sex-mismatch cardiac allografts.

  2002cited by this paper
• Human mesenchymal stem cells persist, demonstrate site-specific multipotential differentiation, and are present in sites of wound healing and tissue regeneration after transplantation into fetal sheep.

  2001cited by this paper
• Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow.

  2000cited by this paper
• From marrow to brain: expression of neuronal phenotypes in adult mice.

  2000cited by this paper
• Two distinct types of hepatitis in experimental hepatitis B virus infection.

  1980cited by this paper

• Harnessing mesenchymal stromal cells for liver disease therapy: from mechanistic discoveries to clinical breakthroughs.

  2026cites this paper
• Preclinical efficacy assessment of umbilical cord mesenchymal stem cell therapy for acute liver failure

  2025cites this paper
• Mesenchymal stem cell and exosome-based therapy for liver diseases: can it overcome conventional therapeutic inconsistencies?

  2025cites this paper
• Stem cells harvested from different sources ameliorate liver fibrosis: comparative study

  2025cites this paper
• Mesenchymal stem cell therapy as a game-changer in liver diseases: review of current clinical trials

  2025cites this paper
• Efficacy and safety of mesenchymal stem cell therapy in acute on chronic liver failure: a systematic review and meta-analysis of randomized controlled clinical trials

  2025cites this paper
• The paracrine effect of mesenchymal cells: future perspectives

  2025cites this paper
• Human stem cells for decompensated cirrhosis in adults.

  2025cites this paper
• Modular mastery of inflammation: umbilical cord mesenchymal stem cells as a therapeutic frontier

  2025cites this paper
• Hotspots and trends in stem cell therapy for liver fibrosis and cirrhosis: A bibliometric analysis

  2025cites this paper
• Therapeutic evaluation of bone marrow mesenchymal stem cells for hepatitis virus infection: immunoregulation, anti-inflammatory effects, and clinical potential - a systematic review

  2025influential citation
• Effect of bone marrow mononuclear cells therapy on long-term survival of patients with liver cirrhosis: A 10-year retrospective cohort study using propensity score matching

  2025influential citation
• Are mesenchymal stem/stromal cells a novel avenue for the treatment of non-alcoholic fatty liver disease?

  2025cites this paper
• Predicting and optimising outcome for biliary atresia.

  2025cites this paper
• Safety and Effectiveness of Muse Cell Transplantation in a Large-Animal Model of Hepatic Fibrosis

  2025cites this paper
• Mechanisms, efficacy, and future perspectives of cellular-based therapies for liver fibrosis/cirrhosis: focusing on mesenchymal stromal cells

  2025cites this paper
• Efficacy of stem cell therapy in patients with chronic liver disease: an umbrella review of systematic reviews

  2024cites this paper
• Bioreactor-based stem cell therapy for liver fibrosis

  2024cites this paper
• The Immunoregulatory and Regenerative Potential of Activated Human Stem Cell Secretome Mitigates Acute-on-Chronic Liver Failure in a Rat Model

  2024cites this paper
• A comprehensive meta-analysis of stem cell therapy for liver failure: Assessing treatment efficacy and modality.

  2024cites this paper
• Stem Cell Therapy as a Potential Treatment of Non-Alcoholic Steatohepatitis-Related End-Stage Liver Disease: A Narrative Review

  2024cites this paper
• Leveraging stem cells to combat hepatitis: a comprehensive review of recent studies

  2024cites this paper
• Mesenchymal Stem Cells and Erythropoietin Therapy in Acute Liver Failure Induced by D-galactosamine in Rats

  2024cites this paper
• Therapeutic and Safety Promise of Mesenchymal Stem Cells for Liver Failure: from Preclinical Experiment to Clinical Application.

  2023cites this paper
• Efficacy and safety of mesenchymal stem cell therapy in liver cirrhosis: a systematic review and meta-analysis

  2023cites this paper
• Stem cell therapy for hepatocellular carcinoma and end-stage liver disease

  2023cites this paper
• Meta-analysis on last ten years of clinical injection of bone marrow-derived and umbilical cord MSC to reverse cirrhosis or rescue patients with acute-on-chronic liver failure

  2023cites this paper
• Isolation, culture, and delivery considerations for the use of mesenchymal stem cells in potential therapies for acute liver failure

  2023cites this paper
• Multiple Dimensions of using Mesenchymal Stem Cells for Treating Liver Diseases: From Bench to Beside

  2023cites this paper
• Enhancing mesenchymal stem cell survival and homing capability to improve cell engraftment efficacy for liver diseases

  2023cites this paper
• Application on Mesenchymal Stem Cells in the Treatment of Chronic Liver Disease

  2023cites this paper
• Autologous bone marrow infusion via portal vein combined with splenectomy for decompensated liver cirrhosis: A retrospective study

  2023cites this paper
• Future Approaches and Therapeutic Modalities for Acute-on-Chronic Liver Failure.

  2023cites this paper
• Mesenchymal stem cells promote polarization of M2 macrophages in mice with acute-on-chronic liver failure via Mertk/JAK1/STAT6 signaling.

  2023cites this paper
• Therapeutic Efficiency of Nasal Mucosa-Derived Ectodermal Mesenchymal Stem Cells in Rats with Acute Hepatic Failure

  2023cites this paper
• Recent progress in microneedle-based cell delivery and cell sampling for biomedical applications.

  2023cites this paper
• Liver Disease and Cell Therapy: Advances Made and Remaining Challenges

  2023cites this paper
• Manipulating HGF signaling reshapes the cirrhotic liver niche and fills a therapeutic gap in regeneration mediated by transplanted stem cells.

  2023cites this paper
• Human Hepatocyte Transplantation: Three Decades of Clinical Experience and Future Perspective

  2023cites this paper
• Mesenchymal Stem Cell Therapy in Acute Liver Failure

  2023cites this paper
• Cell transplantation-based regenerative medicine in liver diseases

  2023cites this paper
• Mesenchymal Stem Cell Transplantation in Liver Diseases.

  2022cites this paper
• Human stem cells for decompensated cirrhosis in adults

  2022cites this paper
• Adult Stem Cell Therapy as Regenerative Medicine for End-Stage Liver Disease.

  2022cites this paper
• Mesenchymal Stem Cell Therapeutic Potential in Regenerative Medicine and Its Future Direction

  2022cites this paper
• Mesenchymal stem cells-based therapy in liver diseases

  2022cites this paper
• Visual analysis of mesenchymal stem cell research in liver disease based on bibliometrics

  2022influential citation
• The assessment of mesenchymal stem cells therapy in acute on chronic liver failure and chronic liver disease: a systematic review and meta-analysis of randomized controlled clinical trials

  2022cites this paper
• Mesenchymal stromal cells (MSCs) and their exosome in acute liver failure (ALF): a comprehensive review

  2022cites this paper
• Mesenchymal Stem Cell Transplantation for hepatitis B virus-related acute-on-chronic liver failure:A systematic review and meta-analysis.

  2022cites this paper
• Human umbilical cord blood mesenchymal stem cells as a potential therapy for schistosomal hepatic fibrosis: an experimental study

  2022cites this paper
• Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives

  2022cites this paper
• Adipose-Derived Mesenchymal Stromal/Stem Cell Line Prevents Hepatic Ischemia/Reperfusion Injury in Rats by Inhibiting Inflammasome Activation

  2022cites this paper
• Mesenchymal stromal cells: promising treatment for liver cirrhosis

  2022cites this paper
• Phase 1 clinical trial for intravenous administration of mesenchymal stem cells derived from umbilical cord and placenta in patients with moderate COVID-19 virus pneumonia: results of stage 1 of the study.

  2022cites this paper
• CCR2-overexpressing mesenchymal stem cells targeting damaged liver enhance recovery of acute liver failure

  2022cites this paper
• Autologous bone marrow mononuclear cell infusion for liver cirrhosis after the Kasai operation in children with biliary atresia

  2022cites this paper
• The Potential Clinical Use of Stem/Progenitor Cells and Organoids in Liver Diseases

  2022cites this paper
• H3K9 acetylation modification and TLR9 immune regulation mechanism in patients after anti-HBV treatment

  2022cites this paper
• Mesenchymal Stem Cell-Derived Exosome Therapy of Microbial Diseases: From Bench to Bed

  2022cites this paper
• Stem cell therapy: a novel approach against emerging and re-emerging viral infections with special reference to SARS-CoV-2

  2022cites this paper
• Cellular Therapies in Pediatric Liver Diseases

  2022cites this paper
• Mesenchymal stem cell homing to improve therapeutic efficacy in liver disease

  2022cites this paper
• Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial

  2021cites this paper
• The impact of recipient age on the effects of umbilical cord mesenchymal stem cells on HBV-related acute-on-chronic liver failure and liver cirrhosis

  2021cites this paper
• CCR2-overexpressing mesenchymal stem cells targeting damaged liver enhance recovery of acute liver failure

  2021cites this paper
• Stem cell transplantation for treating liver diseases: progress and remaining challenges.

  2021cites this paper
• Serum from Acute-on-chronic Liver Failure Patients May Affect Mesenchymal Stem Cells Transplantation by Impairing the Immunosuppressive Function of Cells

  2021cites this paper
• Stem cell therapy in children with acute liver failure: The dream could come true

  2021cites this paper
• Therapeutic efficacy and safety of mesenchymal stem cells transplantation for patients with liver failure: a systematic review and meta-analysis

  2021cites this paper
• A Phase II Dose Escalation Study of Intraarterial (Hepatic) Adult Human Bone Marrow Derived, Cultured, Pooled, Allogeneic Mesenchymal Stromal Cells (Stempeucel®) in Patients with Alcoholic Liver Cirrhosis

  2021cites this paper
• The effect of bone marrow-derived mesenchymal stem cell co-transplantation with hematopoietic stem cells on liver fibrosis alleviation and survival in patients with class III β-thalassemia major

  2021cites this paper
• Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review

  2021cites this paper
• Mesenchymal stem cell therapy for liver disease: current status and future perspectives

  2021cites this paper
• Mesenchymal stromal cells: what have we learned so far about their therapeutic potential and mechanisms of action?

  2021cites this paper
• Adult stem cell transplantation combined with conventional therapy for the treatment of end-stage liver disease: a systematic review and meta-analysis

  2021cites this paper
• Serous Membrane Detachment with Ultrasonic Homogenizer Improves Engraftment of Fetal Liver to Liver Surface in a Rat Cirrhosis Model

  2021cites this paper
• Bone Marrow-Derived Stem Cells for Patients with Liver Cirrhosis: A Systematic Review and Meta-analysis.

  2021cites this paper
• Serous Membrane Detachment with Ultrasonic Homogenizer Improves Engraftment of Fetal Liver to Liver Surface in a Rat Model of Cirrhosis

  2021cites this paper
• Hepatic Regeneration in Cirrhosis.

  2021cites this paper
• Mesenchymal stromal cell therapy alone does not lead to complete restoration of skin parameters in diabetic foot patients within a 3-year follow-up period

  2021cites this paper
• Human Liver Stem Cell Transplantation Alleviates Liver Fibrosis in a Rat Model of CCl4-Induced Liver Fibrosis

  2021cites this paper
• The Clinical Outcomes of Stem Cell Therapy for Decompensated Liver Disease: A Systematic Review and Meta-Analysis

  2021cites this paper
• Mesenchymal Stromal Cells: an Antimicrobial and Host-Directed Therapy for Complex Infectious Diseases

  2021cites this paper
• Current understanding of mesenchymal stem cells in liver diseases

  2021cites this paper
• A case report on intraportal injection of autologous bone marrow-derived mononuclear cells and liver transplantation in a patient with cirrhosis

  2021cites this paper
• Perspective on Stem Cell Therapy in Organ Fibrosis: Animal Models and Human Studies

  2021influential citation
• Cell Transplantation Therapy for Liver Failure

  2020cites this paper
• The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future

  2020cites this paper
• Stem Cell Therapy Delivery in Liver Disease

  2020cites this paper
• Liver Regeneration and Tissue Engineering

  2020cites this paper
• Regenerative medicine for the hepatobiliary system: A review

  2020cites this paper
• Cell Therapy for Advanced Liver Diseases: Repair or Rebuild.

  2020cites this paper
• Mesenchymal stem cell therapy for liver disease: full of chances and challenges

  2020cites this paper
• Recovery Dynamics of Intestinal Bacterial Communities of CCl4-Treated Mice with or without Mesenchymal Stem Cell Transplantation over Different Time Points

  2020cites this paper
• Distinct EpCAM-Positive Stem Cell Niches Are Engaged in Chronic and Neoplastic Liver Diseases

  2020cites this paper
• Mesenchymal Stem Cells Induce a Fibrolytic Phenotype By Regulating mmu-miR-6769b-5p Expression in Macrophages

  2020cites this paper
• Novel Cell-Based Therapies in Hepatic Disorders

  2020cites this paper
• Enhanced therapeutic effects of umbilical cord mesenchymal stem cells after prolonged treatment for HBV-related liver failure and liver cirrhosis

  2020cites this paper
• Cell Biology and Translational Medicine, Volume 9: Stem Cell-Based Therapeutic Approaches in Disease

  2020cites this paper